These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 16719158
21. Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996. Price DA, Wilton P, Jönsson P, Albertsson-Wikland K, Chatelain P, Cutfield W, Ranke MB. Horm Res; 1998; 49(2):91-7. PubMed ID: 9485178 [Abstract] [Full Text] [Related]
22. Recombinant growth hormone therapy in children with short stature in Kuwait: a cross-sectional study of use and treatment outcomes. Al-Abdulrazzaq D, Al-Taiar A, Hassan K, Al-Basari I. BMC Endocr Disord; 2015 Dec 03; 15():76. PubMed ID: 26630987 [Abstract] [Full Text] [Related]
23. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement]. Korpal-Szczyrska M, Dorant B, Kamińska H, Birkholz D, Niedźwiecki M. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 Dec 03; 12(1):31-4. PubMed ID: 16704859 [Abstract] [Full Text] [Related]
24. Growth before and during growth hormone treatment in children operated for craniopharyngioma. Hogeveen M, Noordam C, Otten B, Wit JM, Massa G. Horm Res; 1997 Dec 03; 48(6):258-62. PubMed ID: 9402242 [Abstract] [Full Text] [Related]
25. Pubertal growth in young adult survivors of childhood leukemia. Didcock E, Davies HA, Didi M, Ogilvy Stuart AL, Wales JK, Shalet SM. J Clin Oncol; 1995 Oct 03; 13(10):2503-7. PubMed ID: 7595700 [Abstract] [Full Text] [Related]
26. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency. Esen I, Demirel F, Tepe D, Kara O, Koc N. Growth Horm IGF Res; 2013 Oct 03; 23(5):196-9. PubMed ID: 23890535 [Abstract] [Full Text] [Related]
27. Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: the National Cooperative Growth Study experience. August GP, Julius JR, Blethen SL. Pediatrics; 1998 Aug 03; 102(2 Pt 3):512-6. PubMed ID: 9685455 [Abstract] [Full Text] [Related]
28. Cranial irradiation and early puberty. Ogilvy-Stuart AL, Clayton PE, Shalet SM. J Clin Endocrinol Metab; 1994 Jun 03; 78(6):1282-6. PubMed ID: 8200926 [Abstract] [Full Text] [Related]
29. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation. Hovi L, Saarinen-Pihkala UM, Vettenranta K, Lipsanen M, Tapanainen P. Bone Marrow Transplant; 1999 Nov 03; 24(10):1131-6. PubMed ID: 10578163 [Abstract] [Full Text] [Related]
30. Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood. Bakker B, Oostdijk W, Geskus RB, Stokvis-Brantsma WH, Vossen JM, Wit JM. Clin Endocrinol (Oxf); 2007 Oct 03; 67(4):589-97. PubMed ID: 17590170 [Abstract] [Full Text] [Related]
31. Screening for late effects in brain tumor survivors. Landier W, Kinahan KE, Shaw S, Bhatia S. Cancer Treat Res; 2009 Oct 03; 150():389-409. PubMed ID: 19834683 [No Abstract] [Full Text] [Related]
33. Late neurocognitive sequelae in survivors of brain tumours in childhood. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Lancet Oncol; 2004 Jul 03; 5(7):399-408. PubMed ID: 15231246 [Abstract] [Full Text] [Related]
34. The evolution of spinal growth after irradiation. Clayton PE, Shalet SM. Clin Oncol (R Coll Radiol); 1991 Jul 03; 3(4):220-2. PubMed ID: 1931763 [Abstract] [Full Text] [Related]
35. Intracerebral cavernous hemangioma after cranial irradiation in childhood. Incidence and risk factors. Strenger V, Sovinz P, Lackner H, Dornbusch HJ, Lingitz H, Eder HG, Moser A, Urban C. Strahlenther Onkol; 2008 May 03; 184(5):276-80. PubMed ID: 18427759 [Abstract] [Full Text] [Related]
36. Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): the KIGS experience. Trollmann R, Bakker B, Lundberg M, Doerr HG. Pediatr Rehabil; 2006 May 03; 9(2):144-8. PubMed ID: 16449073 [Abstract] [Full Text] [Related]
37. Undernutrition and Pubertal Timing in Female Survivors of Medulloblastoma and Other Embryonal Tumors. Zhu J, Feldman HA, Chordas C, Wassner AJ, Manley PE, Cohen LE. J Clin Endocrinol Metab; 2020 Oct 01; 105(10):e3650-9. PubMed ID: 32706870 [Abstract] [Full Text] [Related]
38. Endocrine outcome in long-term survivors of low-grade hypothalamic/chiasmatic glioma. Collet-Solberg PF, Sernyak H, Satin-Smith M, Katz LL, Sutton L, Molloy P, Moshang T. Clin Endocrinol (Oxf); 1997 Jul 01; 47(1):79-85. PubMed ID: 9302376 [Abstract] [Full Text] [Related]
39. Growth failure after treatment of pediatric brain tumors. Clarson CL, Del Maestro RF. Pediatrics; 1999 Mar 01; 103(3):E37. PubMed ID: 10049993 [Abstract] [Full Text] [Related]
40. Auxologic and biochemical characterization of the three phases of growth failure in pediatric patients with brain tumors. Meacham LR, Mason PW, Sullivan KM. J Pediatr Endocrinol Metab; 2004 May 01; 17(5):711-7. PubMed ID: 15237704 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]